Novavax, Inc.
NVAX
$8.05
-$0.09-1.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -53.39M | -9.49M | 17.53M | -202.38M | 106.51M |
| Total Depreciation and Amortization | 3.06M | 3.06M | 5.13M | 6.59M | 7.56M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.77M | -982.00K | 11.58M | 137.67M | -1.20M |
| Change in Net Operating Assets | -33.25M | -25.01M | -73.70M | 165.93M | -240.33M |
| Cash from Operations | -72.81M | -32.42M | -39.48M | 107.80M | -127.46M |
| Capital Expenditure | -588.00K | -1.27M | -2.08M | -2.02M | -527.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.49M | -27.09M | 22.56M | -134.51M | 111.63M |
| Cash from Investing | 34.90M | -28.36M | 20.48M | -136.53M | 111.10M |
| Total Debt Issued | 0.00 | 46.41M | 0.00 | 42.61M | -- |
| Total Debt Repaid | -526.00K | -578.00K | -6.27M | -984.00K | -612.00K |
| Issuance of Common Stock | 1.73M | -- | -- | 5.29M | -- |
| Repurchase of Common Stock | -- | -8.16M | -- | -- | -428.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -330.00K | -4.47M | -- |
| Cash from Financing | 1.20M | 37.68M | -6.60M | 42.44M | -1.04M |
| Foreign Exchange rate Adjustments | -176.00K | -18.00K | -1.71M | 658.00K | 7.91M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.89M | -23.13M | -27.31M | 14.38M | -9.50M |